Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yabao Pharmaceutical is a prominent Chinese pharmaceutical enterprise that integrates research, development, manufacturing, and logistics. The company is a market leader in pediatric medicine, particularly known for its proprietary Dinggui Erqi Patch, a traditional Chinese medicine (TCM) treatment for infant diarrhea. Yabao also maintains a robust portfolio in cardiovascular health, endocrinology, and bone health, producing both modern TCM and chemical generics. The Sichuan subsidiary serves as a vital manufacturing and operational hub within the group's national network. With a focus on innovation, the company is advancing a pipeline of small molecule candidates for metabolic and oncological indications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yabao Pharma Sichuan Pharmaceutical.